Cyproterone acetate
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Cyproterone acetate and local guidelines before prescribing.
Antiandrogen
Mechanism
Antiandrogen and progestogen.
Uses
Severe acne and hirsutism (with ethinylestradiol), prostate cancer, hypersexuality.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Hepatotoxicity, meningioma, VTE, depression.
Interactions
Enzyme inducers.
Contraindications and cautions
Liver disease, meningioma
Monitoring
LFT
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Contraindicated in liver disease
Overdose and reversal
Supportive
Special advice
MHRA warning: meningioma with prolonged high dose; stop if LFT abnormal.
More from the textbook: uses, cautions and other points
- Anti-androgens - cyproterone acetate (liver toxicity, meningioma risk with high doses - MHRA), spironolactone (hirsutism), finasteride (5-alpha-reductase inhibitor - BPH; MHRA warning on depression and suicidal thoughts and sexual side effects).
Endocrine: Anatomy Physiology and Pharmacology
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)